期刊文献+

中成药上市后临床合理用药评价要点 被引量:3

Evaluation point of rational drug use of traditional Chinese medicine in market
原文传递
导出
摘要 遵循安全、有效、经济的原则使用药物,使用药者承受最小风险获得最大受益,是临床合理用药的要求和目的,该文结合上市后中药临床应用的特点,从是否遵循了安全用药的原则,用药后是否获得了预期的疗效,用药价格对患者是否适宜3个方面分析了中药上市后合理用药的评价要点,提出了要结合中医药特点,建立中药上市后合理用药评价体系,进一步完善中药上市后的临床用药方案,指导临床合理用药。 Minimizing the underlying risk and maximizing the benefits of drag users, by using drags under a safe, efficient and economical principle, is both the requirement and purpose of clinical rational drug use. This paper evaluates the clinical application of traditional Chinese medicine (TCM) in the market based on its characteristics, considering if the drugs are safely applied, if the medicine has an anticipated effect, and if the medicine is properly priced. This paper also brings the idea of establishing an evaluation system integrated with the characteristics of TCM to monitor the clinical application of TCM after going into the market and thus further optimizes the clinical instructions of applying TCM and helps to guide the appropriate usage of TCM.
出处 《中国中药杂志》 CAS CSCD 北大核心 2011年第20期2807-2810,共4页 China Journal of Chinese Materia Medica
基金 国家"重大新药创制"科技重大专项(2009ZX09502-030) 中国中医科学院自主选题研究项目(Z0133)
关键词 中药 上市后 合理用药 评价 traditional Chinese medicine(TCM) in the market rational drug use evaluation
  • 相关文献

参考文献5

二级参考文献18

共引文献358

同被引文献36

引证文献3

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部